Biologics and Genetic Therapies
Intrinsik supports clients developing biologics and genetic therapies, including monoclonal antibodies (MAbs), proteins, nucleotides, vaccines, blood products, cell and tissue products, and biologic-drug conjugates.
Our scientists have the expertise to address your complex
toxicological health and environmental issues, including product
development and business risks to avoid scientific and regulatory delays.